The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease
Authors:
- 29 April 2014
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 10 (7) , 422-428
Abstract
A high proportion of peripheral human B cells produce polyreactive or autoreactive antibodies, which indicates that they have escaped the elimination of self-reactive B cells in the bone marrow. CD22 and Siglec-G are two inhibitory receptors of the sialic-acid-binding immunoglobulin-like lectin (Siglec) family that inhibit the B-cell antigen receptor (BCR) signal. The ability of these two receptors to bind sialic acids is crucial for regulating inhibition and inducing tolerance to self-antigens. Sialylated glycans are usually absent on microbes (although several pathogenic microorganisms have evolved strategies to mimic self by decorating their surfaces with sialic acids) but abundant in higher vertebrates and might, therefore, provide an important tolerogenic signal. Combined Siglec-G deficiency and CD22 deficiency leads to spontaneous autoimmunity in mice, and mutations in an enzyme that modifies Siglec ligands are directly linked to several autoimmune diseases in humans. New data show that high-affinity ligands for CD22 and Siglec-G can be used to induce antigen-specific B-cell tolerance, which might be one strategy for the treatment of autoimmune diseases in the future.Keywords
This publication has 54 references indexed in Scilit:
- Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosisJournal of Clinical Investigation, 2013
- CD22 ligation inhibits downstream B cell receptor signaling and Ca2+ flux upon activationArthritis & Rheumatism, 2012
- Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?Immunology, 2010
- Functionally defective germline variants of sialic acid acetylesterase in autoimmunityNature, 2010
- Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoJournal of Experimental Medicine, 2009
- Genetic susceptibility to SLE: new insights from fine mapping and genome-wide association studiesNature Reviews Genetics, 2009
- Sialylated multivalent antigens engage CD22in transand inhibit B cell activationProceedings of the National Academy of Sciences, 2009
- B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esteraseJournal of Experimental Medicine, 2008
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Expression of aberrant forms of CD22 on B lymphocytes in Cd22a lupus-prone mice affects ligand bindingInternational Immunology, 2005